R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 15

J Comp Eff Res. 2024 May;13(5):e240033. doi: 10.57264/cer-2024-0033. Epub 2024 Mar 28.

Abstract

In this latest update we discuss real-world evidence (RWE) guidance from the leading oncology professional societies, the American Society of Clinical Oncology and the European Society for Medical Oncology, and the PRINCIPLED practical guide on the design and analysis of causal RWE studies.

Keywords: ASCO; American Society of Clinical Oncology; ESMO; ESMO-GROW; European Society for Medical Oncology; PRINCIPLED; US Food and Drug Administration; artificial intelligence; data quality; health technology assessment; inferential studies; oncology; real-world data; real-world evidence; regulatory; target trial emulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Comparative Effectiveness Research / economics
  • Comparative Effectiveness Research / methods
  • Humans
  • Medical Oncology / economics
  • Reimbursement Mechanisms
  • Research Design
  • Technology Assessment, Biomedical* / economics
  • Technology Assessment, Biomedical* / methods